RESULTS OF USING STAPLELESS MINI-GASTRIC BYPASS FOR THE TREATMENT OF THE METABOLIC SYNDROME
https://doi.org/10.17238/issn2223-2427.2019.2.5-10
Abstract
In the present article, after assessment of the effectiveness of the developed stapleless mini-gastric bypass was described on equally effective of the stapleless and standard stapler methods of treating the metabolic syndrome
About the Authors
O. B. Ospanov
Astana Medical University; University Medical Center
Kazakhstan
Kazakhstan
Oral B. Ospanov, MD, PhD, Professor
Syganak str., 5/1, rv.48, Z05K7B9, Nur-Sultan
G. A. Eleuov
University Medical Center
Kazakhstan
Kazakhstan
Galymgan A. Eleuov, MD, PhD
F. K. Bekmurzinova
University Medical Center
Kazakhstan
Kazakhstan
Farida K. Bekmurzinova, bachelor
58V Melnichnaya street, 644036 Omsk
References
1. Benraouane F., Litwin S.E. Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol, 2011, 26(6), pp. 555–561. doi:10.1097/HCO.0b013e32834b7fc4
2. Sjöström L., Narbro K., Sjöström C. The Swedish Obese Subjects Study Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med, 2007, 357, pp. 741-752.
3. Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol, 2014, 20(41), pp. 15135–15143. doi:10.3748/wjg.v20.i41.15135
4. Ospanov O.B. OBES SURG, 2016, 26, p. 2268. https://doi.org/10.1007/s11695-016-2281-2.
5. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 2006 May, 23(5), pp. 469-80. Review. PubMed PMID: 16681555.
6. Carbajo M., García-Caballero M., Toledano M. et al. OBES SURG,2005,15,p.398. https://doi.org/10.1381/0960892053576677
7. Barzin M., Khalaj A., Motamedi M.A., Shapoori P., Azizi F., Hosseinpanah F. Safety and effectiveness of sleeve gastrectomy versus gastric bypass: one-year results of Tehran Obesity Treatment Study (TOTS). Gastroenterol Hepatol Bed Bench, 2016, 9(Suppl1), pp. S62–S69.
8. Kraljević M., Delko T., Köstler T. et al. Laparoscopic Rouxen-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial. Trials, 2017, 18(1), p. 226. doi:10.1186/s13063-017-1957-9.
9. Rubino F., Schauer P.R., Kaplan L.M., Cummings D.E. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med, 2010, 61, pp. 393-411. doi: 10.1146/annurev.med.051308.105148. Review. PubMed PMID: 20059345.
10. Adam S., Liu Y., Siahmansur T., Ho J.H., Dhage S.S., Yadav R., New J.P., Donn R., Ammori B.J., Syed A.A., Malik R.A., Soran H., Durrington P.N. Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6. Diab Vasc Dis Res, 2019 Mar, 16(2), pp. 144-152. doi: 10.1177/1479164119826479. PubMed PMID: 31014098.
11. Brethauer Stacy A. et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surgery for Obesity and Related Diseases , Volume 11 , Issue 3 , pp. 489 – 506. DOI: https://doi.org/10.1016/j.soard.2015.02.003.
12. Schiavon C.A., Bersch-Ferreira A.C., Santucci E.V. et al. Effects of Bariatric Surgery in Obese Patients with Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation, 2018, 137(11), pp. 1132–1142. doi:10.1161/CIRCULATIONAHA.117.032130.
13. Harchaoui K.E., Visser M.E., Kastelein J.J., Stroes E.S., Dallinga-Thie G.M. Triglycerides and cardiovascular risk. Curr Cardiol Rev. 2009, 5(3), pp. 216–222. doi:10.2174/157340309788970315.
14. Hokanson John E., Melissa A. Austin. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. Journal of cardiovascular risk, 1996, pp. 213-219.
15. Lu Y., Hajifathalian K., Ezzati M., Woodward M., Rimm E.B, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet, 2014 Mar, 15, 383(9921), pp. 970-83. doi: 10.1016/S0140-6736(13)61836-X. PubMed PMID: 24269108; PubMed Central PMCID: PMC3959199.
Review
For citations:
Ospanov O.B., Eleuov G.A., Bekmurzinova F.K. RESULTS OF USING STAPLELESS MINI-GASTRIC BYPASS FOR THE TREATMENT OF THE METABOLIC SYNDROME. Surgical practice (Russia). 2019;(2):5-10. (In Russ.) https://doi.org/10.17238/issn2223-2427.2019.2.5-10
Views:
478
Email this article 
